HTA approves 78 living organ donations in February 2024
In February, a total of 78 living organ donations were approved across all four nations.
Public
HTA Board Meeting - 7 March 2024
Human Tissue Authority Board Meeting agenda and papers.
HTA approves 94 living organ donations in January 2024
In January, a total of 94 living organ donations were approved across all four nations.
HTA data for quarter three of 2023 to 2024
Today we are publishing data about incidents reported to HTA during quarter three of 2023 to 2024. We are also publishing our workforce and expenses information.
HTA licensed establishments in the Post Mortem, Human Application and Organ Donation and Transplantation sector are required to report incidents to the HTA as part of their licensing requirements.
In the post-mortem sector we call these HTARIs, and those in the Human Application and Organ Donation and Transplantation sectors are called Serious Adverse Events or Reactions (SAEARs).
Working in University research
I am Designated Individual (DI) for the University of Warwick’s HTA Research Licence, which covers two sites, one at the University campus and the other in laboratory space that the University rents from a local NHS Trust. We have five departments where human tissue is used in research, with great diversity in the projects, tissue types and characters involved in the research.
HTA Board - 7 December 2023
Human Tissue Authority Board Meeting agenda and papers
HTA approves 98 living organ donations in December 2023
In December, a total of 98 living organ donations were approved across all four nations.
HTA approves 90 living organ donations in November 2023
In November, a total of 90 living organ donations were approved across all four nations.
Human Tissue Authority welcomes three new Board members
The Human Tissue Authority (HTA) is pleased to announce that the Secretary of State for Health and Social Care has appointed three new Board members for the Authority. They will join the HTA with effect from 1st December 2023.
Chair of the HTA, Lynne Berry CBE, has commented:
HTA statement on the Fuller Independent Inquiry phase one report
Statement from Chief Executive Dr Colin Sullivan on the phase one report of the Fuller Independent Inquiry